Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The long reach of childhood income inequality: a multinational twin study of gene-environment interplay on adult depressive symptoms.

Psychological medicine·2026
Same author

Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron disease.

Human molecular genetics·2026
Same author

Subjective Sleep Traits and Cognition Across Mid- to Late-Adulthood: A Cross-Sectional Study of Gene-Environment Interplay.

Sleep·2026
Same author

Evaluating a Genome-Wide Polygenic Score for Handgrip Strength and its Interplay with Leisure-Time Physical Activity Across the IGEMS Twin Cohorts.

Medicine and science in sports and exercise·2026
Same author

Druggable genome-wide Mendelian randomization analysis identifies potential treatment targets in vascular dementia.

Alzheimer's & dementia (New York, N. Y.)·2026
Same author

The heritability of social connections among older adults and their associations with mental and cognitive health: Older Australian Twins Study.

The British journal of psychiatry : the journal of mental science·2026

Related Experiment Video

Updated: Jun 5, 2026

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

Pathway-based analysis using reduced gene subsets in genome-wide association studies.

Jingyuan Zhao1, Simone Gupta, Mark Seielstad

  • 1Human Genetics, 60 Biopolis Street 02-01, Genome Institute of Singapore, 138672 Singapore.

BMC Bioinformatics
|January 14, 2011
PubMed
Summary

This study introduces a new pathway analysis method for Genome-Wide Association Studies (GWAS) to improve the detection of genetic variants associated with complex diseases like psoriasis. The method enhances power to identify susceptibility pathways and associated genes.

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Experiment Videos

Last Updated: Jun 5, 2026

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Area of Science:

  • Genetics
  • Bioinformatics
  • Computational Biology

Background:

  • Genome-Wide Association Studies (GWAS) often miss genetic variants with small marginal effects.
  • Pathway analysis using biological information can reveal complex disease mechanisms.
  • Analyzing entire pathways can lead to reduced statistical power if only a subset of genes is relevant.

Purpose of the Study:

  • To propose a novel pathway-based method for analyzing GWAS data.
  • To enhance the power of detecting associated pathways and genes in complex diseases.
  • To investigate joint gene effects within pathways using a pre-selected gene subset.

Main Methods:

  • Developed a pathway-based method focusing on pre-selected gene subsets.
  • Each gene is treated as the basic unit, reducing the number of variants analyzed.
  • Applied the method to GWAS data and used simulations to evaluate performance.

Main Results:

  • Identified 6 biologically plausible pathways associated with psoriasis in a GWAS dataset.
  • The identified pathways show overlap with previously reported findings.
  • Simulations demonstrated superior power compared to other methods for detecting associated pathways.

Conclusions:

  • The proposed method increases the power to discover susceptibility pathways in GWAS.
  • It facilitates the identification of associated genes within these pathways.
  • The analysis of genome-wide psoriasis data successfully identified relevant pathways.